Post hoc analysis of TALOS-AMI in 859 patients with diabetes after MI and PCI: 1-month de-escalation from ticagrelor to clopidogrel was associated with fewer combined events, as in non-diabetics; bleeding (HR 0.48) and ischaemic (HR 0.57) differences were non-significant.
Secondary analysisn = 859 patients
Kim et al. De-Escalation Dual Antiplatelet Strategy in Stabilized Myocardial Infarction Patients With Diabetes Mellitus